Uk Mhra Gmp
SYMBIOSIS PHARMACEUTICAL SERVICES LIMITEDSYMBIOSIS PHARMACEUTICAL SERVICES LIMITED – UK MHRA GMP Certificate UK MIA(IMP) 40211 Insp IMP 40211/405290-0019[I]
Record Details
This Uk Mhra Gmp record concerns SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED, with an inspection on February 4, 2025, issued by the MHRA, covering drugs.
- Compliance status
- GMPC
- Certificate type
- IMP
- Inspection date
- February 4, 2025
- Issued
- February 9, 2026
- MIA number
- UK MIA(IMP) 40211
- Site address
- SCION HOUSE, STIRLING UNIVERSITY INNOVATION PARK, STIRLING, FK9 4NF, UNITED KINGDOM
- Country
- UNITED KINGDOM
- Products
- Human Investigational Medicinal Products
- Manufacturing operations
- 1. MANUFACTURING OPERATIONS [ 1.1 ] Sterile Investigational Medicinal Products [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) [ 1.1.1.2 ] LyophilisatesCytotoxics [ 1.1.1.4 ] Small volume liquidsCytotoxics [ 1.1.1.6 ] Other aseptically prepared productsSuspensionsCytotoxics [ 1.1.3 ] Batch certification [ 1.2 ] Non-sterile investigational medicinal products [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) [ 1.2.1.17 ] Other non-sterile medicinal productsLyophilisation of non-sterile active ingredients / excipients for use as starting materials in solid oral dosage manufacturing elsewhereCytotoxics [ 1.2.2 ] Batch certification [ 1.3 ] Biological investigational medicinal products [ 1.3.1 ] Biological medicinal products [ 1.3.1.2 ] Immunological products [ 1.3.1.4 ] Gene therapy products [ 1.3.1.5 ] Biotechnology products [ 1.3.1.8 ] Other biological medicinal productsPlasmid, DNA, RNA. peptides. proteins and antibodies products. This list is only indicative of the product handled.Cytotoxics [ 1.3.2 ] Batch certification [ 1.3.2.2 ] Immunological products [ 1.3.2.4 ] Gene therapy products [ 1.3.2.5 ] Biotechnology products [ 1.3.2.8 ] Other biological medicinal productsPlasmid, DNA, RNA. peptides. proteins and antibodies products. This list is only indicative of the product handled.Cytotoxics [ 1.4 ] Other products or manufacturing activity [ 1.4.2 ] Sterilisation of active substances/excipients/finished products: [ 1.4.2.1 ] Filtration [ 1.5 ] Packaging [ 1.5.2 ] Secondary packaging 2. IMPORTATION OF MEDICINAL PRODUCTS [ 2.2 ] Batch certification of imported medicinal products [ 2.2.3 ] Biological medicinal products [ 2.2.3.4 ] Gene therapy products [ 2.3 ] Other Importation Activities [ 2.3.1 ] Site of Physical Importation [ 2.3.2 ] Importation of Intermediate which undergoes further processing
- Restrictions
- MIA(IMP) packaging operations restricted to open label, non-randomised activities.
View Company Profile
ID · 7f2bcca0-6a09-4bd4-8709-3d9772cd5ce4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.